Injectable and topical local anesthetics for acute dental pain
The Journal of the American Dental Association · 2023
DOI: 10.1016/j.adaj.2022.10.014 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift The Journal of the American Dental Association, 2023. Verfasst von Anna Miroshnychenko und 13 weiteren Autor:innen. Hauptthemen laut MEDLINE: Acute Pain, Pulpitis. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: FDA HHS, US Food and Drug Administration, Government of South Australia.
Abstract (Originalsprache)
BACKGROUND: Local anesthesia is essential for pain control in dentistry. The authors assessed the comparative effect of local anesthetics on acute dental pain after tooth extraction and in patients with symptomatic irreversible pulpitis. TYPES OF STUDIES REVIEWED: The authors searched MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, and the US Clinical Trials registry through November 21, 2020. The authors included randomized controlled trials (RCTs) comparing long- vs short-acting injectable anesthetics to reduce pain after tooth extraction (systematic review 1) and evaluated the effect of topical anesthetics in patients with symptomatic pulpitis (systematic review 2). Pairs of reviewers screened articles, abstracted data, and assessed risk of bias using a modified version of the Cochrane risk of bias 2.0 tool. The authors assessed the certainty of the evidence using the Grading of Recommendations Assessment, Development and Evaluation approach. RESULTS: Fourteen RCTs comparing long- vs short-acting local anesthetics suggest that bupivacaine may decrease the use of rescue analgesia and may not result in additional adverse effects (low certainty evidence). Bupivacaine probably reduces the amount of analgesic consumption compared with lidocaine with epinephrine (mean difference, -1.91 doses; 95% CI, -3.35 to -0.46; moderate certainty) and mepivacaine (mean difference, -1.58 doses; 95% CI, -2.21 to -0.95; moderate certainty). Five RCTs suggest that both benzocaine 10% and 20% may increase the number of people experiencing pain reduction compared with placebo when managing acute irreversible pulpitis (low certainty). PRACTICAL IMPLICATIONS: Bupivacaine may be superior to lidocaine with epinephrine and mepivacaine with regard to time to and amount of analgesic consumption. Benzocaine may be superior to placebo in reducing pain for 20 through 30 minutes after application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Förderung
- FDA HHS
- US Food and Drug Administration
- Government of South Australia
- U.S. Department of Health and Human Services
- Bayer HealthCare
Zitieren
APA
Miroshnychenko, A., Ibrahim, S., Azab, M., Roldan, Y., Diaz Martinez, J. P., Tamilselvan, D., He, L., Urquhart, O., Tampi, M., Polk, D. E., Moore, P. A., Hersh, E. V., Carrasco-Labra, A., & Brignardello-Petersen, R. (2023). Injectable and topical local anesthetics for acute dental pain. The Journal of the American Dental Association. https://doi.org/10.1016/j.adaj.2022.10.014
Vancouver
Miroshnychenko A, Ibrahim S, Azab M, Roldan Y, Diaz Martinez JP, Tamilselvan D, et al. Injectable and topical local anesthetics for acute dental pain. The Journal of the American Dental Association. 2023. doi:10.1016/j.adaj.2022.10.014
BibTeX
@article{Miroshnychenko2023,
author = {Miroshnychenko, Anna and Ibrahim, Sara and Azab, Maria and Roldan, Yetiani and Diaz Martinez, Juan Pablo and Tamilselvan, Divyalakshmi and He, Leon and Urquhart, Olivia and Tampi, Malavika and Polk, Deborah E and Moore, Paul A and Hersh, Elliott V and Carrasco-Labra, Alonso and Brignardello-Petersen, Romina},
title = {Injectable and topical local anesthetics for acute dental pain},
journal = {The Journal of the American Dental Association},
year = {2023},
doi = {10.1016/j.adaj.2022.10.014}
}
EUVIMED